
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Aiosyn is a Dutch healthtech company that is developing precision pathology software solutions for breast cancer and chronic kidney disease. Aiosyn launched its first automated QC test on the EU market (AiosynQC) and the first clinical diagnostic test for breast cancer is pending regulatory approval in the EU. With our NephroPath platform we support CROs and Biopharma with quantifying kidney biomarkers thereby accelerating (pre-)clinical drug development studies
Medical imaging,machine learning,neural networks,computer vision,data science,cancer,computer-aided diagnostics,anatomical pathology,and research and development
Aiosyn operates in the Medical equipment manufacturing industry.
Aiosyn's revenue is 11m - 100m
Aiosyn has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.